Skip to content

The study of effectiveness repetitive transcranial magnetic stimulation (rTMS) on anhedonia and rumination in patients with major depression

The study of effectiveness of repetitive transcranial magnetic stimulation (rTMS) on anhedonia, rumination with their related neural circuits in patients with major depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100615004191N3
Enrollment
60
Registered
2018-02-06
Start date
2016-12-21
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depression disorder. Major depressive disorder, recurrent

Interventions

Intervention 1: Intervention group: Repetitive transcranial magnetic stimulation. Intervention 2: Control group: Sham repetitive transcranial magnetic stimulation.

Sponsors

Atieh Clinical Neuroscience Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Outpatients male and female with the range of 18-70 years of age The diagnosis of Major depressive disorder according to DSM-V Having BDI>14 Having stable symptoms as defined by not requiring a change in medication for at least 4 weeks Completion of consent form Being under supervision of a psychiatrist

Exclusion criteria

Exclusion criteria: The history of rTMS treatment for any reason Cardiac pacemaker The risk of seizure with any reasons Pregnancy High risk of suicide Intracranial implant and other ferromagnetic materials close to the head co-morbidity with disorders in axis I and II

Design outcomes

Primary

MeasureTime frame
Anhedonia. Timepoint: baseline, ten session. Method of measurement: Snaith-Hamilton Pleasure Scale (SHAPS).;Rumination. Timepoint: baseline, ten session. Method of measurement: Ruminative Response Scale (RRS).;Anhedonia network. Timepoint: baseline, ten session. Method of measurement: EEG.;Default mode network. Timepoint: baseline, ten session. Method of measurement: EEG.

Secondary

MeasureTime frame
Score of depression. Timepoint: baseline, ten session. Method of measurement: Hamilton Depression Rating Scale.;Score of anxiety. Timepoint: baseline, ten session. Method of measurement: Hamilton Anxiety Rating Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Kazemi

Atieh Clinical Neuroscience Center

rezakazemi@ut.ac.ir+98 21 8401 2138

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026